The non-concealed placebo: a randomized trial on smoking cessation

An open-label randomized interventional study to assess the effect of placebo smoking cessation patches versus no treatment on nicotine dependence scores of adult Filipino smokers

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN64013828

Enrollment

Registered

2016-03-08

Start date

2015-07-10

Completion date

Unknown

Last updated

2017-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking addiction Mental and Behavioural Disorders

Interventions

There were two arms in the study, the placebo patch group and the control group. 1. Both groups: 1.1. Gave informed consent 1.2. Were within the inclusion and exclusion criteria of the study 1.3. Wer

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.18 years or older 2. Male or female 3. Current smoker for 2 years 4. Very willing to quit smoking when assessed with 5 point commitment scale 5. Willing to use the placebo patch for a period of 2 months 6. Ethnically Filipino and currently residing in Sampaloc, Manila 7. Has signed the informed consent form and is aware of the purpose of the study

Exclusion criteria

Exclusion criteria: 1. Taking other smoking cessation treatment/ treatments (e.g. nicotine patches or gum) 2. Is under or have underwent smoking cessation counseling

Design outcomes

Primary

Measure	Time frame
Nicotine dependence, measured using the Fagerstrom test for Nicotine Dependence(FTND) at 0,28 and 56 days after provision of patches	—

Secondary

Measure	Time frame
Cigarettes per day, measured at 0,28 and 56 days after provision of patches	—

Countries

Philippines

Contacts

Public ContactKevyn Yu

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026